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Abstract
Background: To examine the psychometric properties of the Adolescent Depression Rating Scale
(ADRS), a new measure was specifically designed to evaluate adolescent depression.
Methods:  The 11-item clinician-report and 44-item self-report versions of the ADRS were
developed from a qualitative phase involving interviews of experts and adolescents. These two
instruments were then administered to 402 French speaking adolescents with and without
depressive disorders. Item distribution, internal consistency, convergent validity, discriminant
validity and factorial structure were assessed.
Results: After reduction procedures, a 10-item clinician version and a 10-item self-report version
were obtained. The ADRS demonstrated good internal consistency (alpha Cronbach coefficient
>.70). It also discriminated better between adolescents with and without depression than the
Hamilton Depressive Rating Scale and the Beck Depression Inventory (BDI-13).
Conclusion:  The ADRS is a useful, short, clinician-report and self-report scale to evaluate
adolescent depression. Further studies to replicate our findings and evaluate ADRS sensitivity to
effects of treatment and psychometric properties in populations of adolescents with several
psychiatric disorders are warranted.
Background
Standardized diagnostic criteria for depression have raised
several questions regarding the classification of adoles-
cents with depression. In fact, dichotomizing the popula-
tion into cases and non-cases does not take into account
that a substantial proportion of depressed adolescents
have sub-syndromal depressive symptomatology [1]. Yet
these young people have significant morbidity and are at
high risk of developing full-blown major depression [2].
Recent findings [4,24] support the view that measures of
depression in adolescence are best implemented in a
dimensional model, where depressive disorders are con-
ceptualized as a continuum of severity, from mild to
severe. Thus, subjects who meet DSM-IV diagnostic crite-
ria for MDD [3] represent the extreme of a continuum
rather than a distinct group [4].
The feasibility of clinical trials in adolescent populations
depends on the availability of valid measures [5]. In fact,
many studies have utilized depression scales despite lim-
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ited data regarding their validity with young people. For
adolescents aged 13 and older, the most widely used self-
reports include the Centre for Epidemiological Studies
Depression Scale (CES-D) [6] and the Beck Depression
Inventory (BDI) [7]. Likewise, the most frequently used
clinician reports include the Hamilton Depression Rating
Scale (HDRS) [8,9], the Montgomery-Asberg Depression
Rating Scale (MADRS) [10], and the Children's Depres-
sion Rating Scale CDRS-R [11]. However, these instru-
ments are not specific to adolescents, lack construct
validity, and have limited or unknown reliability and
validity in this age group [12-14].
Following the dimensional perspective outlined by Fer-
gusson, the main aim of our study was to design and val-
idate a dimensional scale, the Adolescent Depression
Rating Scale (ADRS) to quantify the intensity of depres-
sion in adolescents aged from 13 to 20 years. On the basis
of recommendations by Myers and Winters [13,14] (con-
struct validity as the core of depression rating scale devel-
opment, the use of two scales – self report and clinician
versions – to obtain a robust measure, both having short
forms to facilitate reiterated and longitudinal assess-
ments), the decision was made to develop two versions of
the ADRS: a self-report and a clinician-report instrument.
The clinician-report ADRS is designed to be used in clini-
cal and research settings and the self-report ADRS for epi-
demiological studies.
This paper reports on the validation of the French version
of the ADRS. This validation is based on a multi-centre
study in France, Belgium and Switzerland. A validation
study is presently in progress for the English, Spanish,
Chinese, Arabic, and Hebrew versions of the instrument.
Methods
Scale construction
The first phase was qualitative and designed for item gen-
eration and construction; it was based on four steps:
1. Apprehension of depression in adolescents via detailed
exploration of the literature (Medline, PsycInfo, from
June 1993 to June 2003, keywords: adolescent, depressive
disorders, psychometrics, rating scales).
2. Qualitative studies on research interviews of 11 experi-
enced clinicians in adolescent psychiatry (from 15 to 25
years of experience in adolescent psychiatry) and 5
depressed adolescents, to identify facets of adolescent
depression (question grid in Annex, see additional file 1).
The task was 1/to apprehend psychiatrists' representations
of depressive disorders in adolescents, 2/to get an idea of
experiences and practice, 3/to describe decisional steps for
each clinician, 4/to apprehend in as neutral a manner as
possible the symptomatic expression of the depressive
experience, from the adolescent patient verbatim. These
qualitative data were analyzed using an adaptation of
Colaizzi's method [15], pinpointing the categories of
depressive experience that emerged from the interviews.
Features identified were grouped into themes, and then
into theme clusters with common traits, and finally into
more general categories. Depression in adolescents
appeared as a complex emotional state, involving irritability,
a feeling of being overwhelmed by the depressive experi-
ence, negative perceptions of self, thoughts about death; it
was also found to involve non-emotional manifestations:
mental slowness, sleep disturbances, and manifestations
through social interactions at school, in work, in leisure, and
in relationships with others.
3. Construction of the measure on the basis of the two
previous steps: drafting of the items, and selection of
items using a consensus method.
The ADSR was constructed using the three domains
derived from the qualitative phase : 1) emotional state
involving irritability, a feeling of being overwhelmed by
the depressive experience, negative perceptions of self,
and thoughts about death; 2) non-emotional manifesta-
tions involving mental slowing, and sleep disturbances;
3) clinical manifestations through social interactions at
school, in work and leisure, and in relationships with oth-
ers. Two initial versions of the ADRS were constructed: 1)
an 11-item clinician-report scale, the ADRS initial version
for clinicians (ADRSic) with depression severity rated on
a 7-point Likert scale from none to severe, for the previous
two weeks; 2) a 44-item self-report scale, the ADRS initial
version for patients (ADRSip) with true/false responses
(Table 1).
An instruction manual was drafted for the ADRSic
(Annex, see additional file 1).
Validation
Sample and instruments
Four-hundred and nine adolescents, aged 13–20 years,
who attended outpatient clinics or were hospitalized
between November and May 2004 at 15 medical centres
in France, in Brussels (Belgium) and in Geneva (Switzer-
land) were included. The patients recruited were all receiv-
ing treatment but not necessarily for depression: they were
attending either a psychiatric clinic or an adolescent med-
icine clinic (80%; 20%).
Subjects with mental retardation or psychosis were
excluded. To widen our data to subjects with different lev-
els of depression, care was taken to include a population
with a wide range of disorders and different levels of
depressive severity, from none to severe.BMC Psychiatry 2007, 7:2 http://www.biomedcentral.com/1471-244X/7/2
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All investigators were senior child and adolescent psychi-
atrists who were trained and supervised by the principal
investigator (ARL) to administer the ADRSic. During the
first interview, subjects and their parents were introduced
to the nature of the study and asked to sign the consent
form. Since this validation study was only observational,
according to French law no authorization from an ethics
committee was necessary.
All adolescents completed the BDI 13-item version [7]
and the ADRSip (44 items). The investigators completed
the ADRSic (11 items), the HDRS 17-item version [8,9],
and the Clinical Global Impression Scale (CGI) severity
scale [16]. Following this, the investigators were asked to
answer a question requiring a clinical judgment by the
investigator: "Based on your experience, do you consider
that this patient is depressed? Does he/she require treat-
ment for this aspect of his/her psychopathology?" Finally,
based on the clinical interview, the investigators com-
pleted the DSM-IV criteria for MDD.
The two variables DSM-IV criteria for MDD (Yes/No) and
clinical judgment (Yes/No) were then used to classify
patients in 3 groups:
Table 1: French initial version of ADRS, patient version (ADRSip)
1. J'arrive à rien en ce moment
2. Je me laisse énerver pour un rien
3. Au fond je ne me sens pas à la hauteur
4. Je n'aime rien en ce moment
5. Mes idées sont en désordre
6. Je me perds dans le travail en ce moment, mais ça ne donne rien
7. Je n'ai pas d'énergie pour l'école, pour le travail
8. Je veux rester couché et dormir
9. Au moins dans mon lit, je ne pense plus à rien
10. J'ai du mal à réfléchir
11. Je sens que la tristesse, le cafard me débordent en ce moment
12. Je n'ai plus de plaisir à faire mes activités comme avant
13. Penser, réfléchir, lire ou travailler me demande un effort
14. Je fais des rêves horribles
15. J'ai peur que ce que tout ça devienne insupportable
16. Je sens bien qu'il vaut mieux que je ne sois pas seul(e)
17. Il n'y a rien qui m'intéresse, plus rien qui m'amuse.
18. J'ai même du mal à supporter mes copains
19. Ce que je fais ne sert à rien
20. J'en peux plus de ma vie en ce moment
21. En ce moment je ne maîtrise pas ce qui se passe
22. L'école, le travail, ça m'intéresse pas en ce moment, j'y arrive pas
23. Je ne supporte rien
24. J'ai du mal à rassembler mes idées
25. Je ne supporte pas grand monde
26. Je peux rester couché des heures à rien faire
27. Je me sens seul à l'intérieur de moi
28. Au fond, quand c'est comme ça, j'ai envie de mourir
29. Je n'arrive pas à me concentrer
30. Je trouve que rien ne vaut la peine en ce moment
31. Je vois bien que je dois me forcer pour l'école, le travail
32. Avec mes amis au moins je ne pense à rien
33. Je ne supporte pas grand chose
34. Ce que je fais ne vaut pas grand chose
35. Je veux absolument pas être tout(e) seule, sinon je sens que ça va pas
36. Je me sens découragé
37. Je trouve tout trop difficile
38. Ces derniers temps, j'ai arrêté mes loisirs, ça me dit plus rien
39. On m'énerve facilement
40. Je dors très mal
41. Je veux rester chez moi et rien faire
42. Je me sens dépassé par ce qui m'arrive
43. A l'école, au boulot, j'y arrive pas
44. Je vais pas pouvoir supporter tout ça longtemps
The modality of response was 'oui/non' (yes/no) for each itemBMC Psychiatry 2007, 7:2 http://www.biomedcentral.com/1471-244X/7/2
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1) No depression: the patients did not meet DSM-IV crite-
ria for MDD and were not considered clinically depressed
by the investigator.
2) Intermediate group: the patients did not meet the
DSM-IV criteria for MDD, but they were considered clini-
cally depressed according the clinical judgment. These
patients were experiencing a form of depression other
than MDD.
3) Depression: the patients met DSM-IV criteria for MDD
and were judged clinically depressed.
As mentioned above, since we were interested in evaluat-
ing the ability of the ADRS to ascertain depressive symp-
tomatology in different levels of depression, the analyses
of our data were performed for these three groups.
Data analysis
First, an item analysis was carried out on the initial ver-
sions, with a close inspection of the distribution of each
item to detect any floor or ceiling effect, or any item
redundancy.
Internal consistency was measured by means of the Cron-
bach coefficient. Concurrent validity was assessed by Pear-
son correlations computed between the HDRS, CGI, BDI
and the ADRSp and ADRSc scores after item reduction.
The factorial structure of the ADRS initial and final ver-
sions was studied with a maximum likelihood factor anal-
ysis with Varimax rotation. The number of factors was
determined from the observation of the screeplot, eigen-
values greater than one, and from the clinical interpreta-
bility of factors [17,18].
Using multiple group confirmatory factor analysis, the
stability of the structure of the ADRS final versions was
studied in relation to age, gender, and depression groups.
To assess the optimal cut-off scores derived from the total
score so as to discriminate between levels of depression,
the receiver operator curve (ROC) method was used [19].
Sensitivity and specificity were computed.
The ability of the ADRS final versions to discriminate
among the different diagnostic groups was explored by
computing the effect sizes across the three groups of
patients defined according to level of depression. HDRS,
CGI, BDI and the ADRSc and ADRSp versions were com-
pared on this basis. The pairwise statistical comparison of
these effect sizes was performed using a bootstrap proce-
dure [20].
The "minimum clinically relevant differences" in ADRSc
and ADRSp scores were estimated from the slope coeffi-
cient of the linear regression of ADRS on CGI [21].
Statistical analyses were performed using the R 2.0 pack-
age with "psy" and "mva" packages. Most psychometric
analyses were replicated by a second statistician using SAS
8.2. Multiple group confirmatory factor analysis was per-
formed with Mplus 2.1 [22].
Results
Sample
Four-hundred and two adolescents aged 16.5 (sd 2.0),
125 males (mean age 16.5 (sd 1.8)), 277 girls (mean age
16.6 (sd 1.9)) were assessed. One-hundred and twenty-six
patients were depressed (mean age 16.4/sd 1.9; 32 males,
94 girls), 139 patients had a depressive experience but no
MDD (mean age 16.6 (sd 1.8); 45 males; 94 girls) and 137
patients were not depressed (mean age 16.7 (sd2.1); 48
males, 89 girls). Seven patients out of 409 patients ini-
tially included were dropped because of missing data.
Item analysis
For both clinician and self-report initial versions of the
ADRS, the proportion of missing data per item was low
Table 2: French and English final version of ADRS patient version (ADRSp)
Item # English version French version
1 I have no energy for work/school Je n'ai pas d'énergie pour l'école, pour le travail
2 I have trouble thinking J'ai du mal à réfléchir
3 I feel overwhelmed by sadness and listlessness Je sens que la tristesse, le cafard me débordent en ce moment
4 Nothing really interests or entertains me Il n'y a rien qui m'intéresse, plus rien qui m'amuse.
5 What I do is useless Ce que je fais ne sert à rien
6 When I feel this way I wish I were dead Au fond, quand c'est comme ça, j'ai envie de mourir
7 Everything annoys me Je ne supporte pas grand-chose
8 I feel downhearted and discouraged Je me sens découragé
9 I sleep badly Je dors très mal
10 School/work doesn't interest me just now, I can't cope. A l'école, au boulot, j'y arrive pas
The items selected from the initial versions are items # 7,10,11,17,18,28,33,36, 40 and 43.
The modality of response was 'vrai/faux' (true/false) for each item.BMC Psychiatry 2007, 7:2 http://www.biomedcentral.com/1471-244X/7/2
Page 5 of 10
(page number not for citation purposes)
Table 3: English final version of ADRS clinician version (ADRSc)
Item # Item title Modality of response points
1 Irritability Absence of any irritability, either self-perceived or perceived by the observer 0
Irritability perceptible or felt in dealings with the subject, although he/she can control it 2
Considerable irritability in dealings with the subject, generating conflict, relational difficulties 4
Intense, overpowering irritability making dealings and exchanges virtually impossible 6
2 Overwhelming experience of depression No depressive feelings or thoughts (= gloominess, despair, sadness) 0
Depressive feelings or thoughts present but controlled and manageable 2
Feeling of being overwhelmed by depressive feelings or thoughts 4
Intense feeling of being overwhelmed by depressive suffering that is devastating and impossible to contain 6
3 Negative perceptions of self Perceptions of self are serene and relevant 0
Tendency to depreciation of self and accomplishments 2
Depreciation of self and accomplishments 4
Self viewed as completely worthless, useless, overpowering despair 6
4 Ideas of death No preoccupation regarding death or suicide 0
Occasional preoccupations regarding death or suicide 2
Recurrent preoccupations regarding death or suicide 4
Pervasive and intrusive ideas regarding death or suicide 6
5 Mental slowing No sign of mental slowness, thought and speech fluid 0
Occasional difficulties in putting ideas together, mental inertia that hinders concentration 2
Considerable difficulty concentrating, obvious repercussions on daily life or school 4
Massive mental inertia, that can result in concentration being impossible or the interview being difficult 6
6 Sleep No sleep disturbance, whether in duration or quality(= sleeplessness, nightmares, not feeling rested, 
sleeping excessively)
0
Occasional sleep disturbance, unusual to the subject 2
Marked, persistent sleep disturbance 4
Major, persistent sleep disturbance, resistant insomnia 6
7 Investment in school, work or job seeking Sustained investment in school or professional activities 0
Loss of motivation for school or work, but activities maintained 2
Marked loss of motivation, disinterest for school or professional activities 4
Total loss of motivation, complete disinterest for school or professional activities 6
8 Investment in non-school activities Interest and enjoyment intact, good investment in usual non-school activities 0
Decrease of enjoyment or interest in usual non-school activities, but these are nonetheless maintained 2
Loss of enjoyment or interest, repeated absence from usual activities, marked narrowing of activities 4
Absence of enjoyment or interest in non-school activities, total cessation of usual activities 6
9 Relationship withdrawal No relational withdrawal 0
Unusual withdrawal from others 2
Relational withdrawal, isolation from others 4
Total isolation 6
10 Perceived empathy from the clinician Interview felt to have occurred in a serene atmosphere 0
Perception of sadness pervading the interview 2
Feeling there was over-riding emotion and/or irrepressible sadness 4
Perception of intense silent distress 6
Intermediate responses are allowed from 0 to 6.
One item has been removed from the initial version: "clinging relationships".BMC Psychiatry 2007, 7:2 http://www.biomedcentral.com/1471-244X/7/2
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(<5%). There was no item responses with floor effect
>50%, or ceiling effect >50%. Inter-item correlation was
<0.70, meaning there was no redundancy.
Factor structure
For the initial version of the clinician-report ADRS over
the whole sample of patients, the screeplot is in favour of
a uni-dimensional instrument, since 44% of variance is
contained in the first principal component while a second
eigenvalue is approximately equal to 1 (1.05). This justi-
fies the use of a single score as a summation of all items.
To explore structure more precisely a factor analysis was
conducted for a 2-factor solutions. This solution was clin-
ically interpretable, with a factor that could be related to
an "internal negative state" including irritability, feelings
of being overwhelmed, negative perception of self, ideas
of death, sleep disturbances and the empathetic percep-
tions of the clinician; and a second factor grouping "exter-
nal manifestations" (including school, leisure activities
and relationships). Most items were clearly attributable to
a single factor except for the item "clinging relationships".
Since this item was sometimes found difficult to rate by
some investigators, it was discarded. On the remaining
10-item ADRSc (table 3), a new series of factor analyses
was performed across the 3 groups defined according to a
level of depression (table 4).
The stability of the two-factor solution was tested across
age (under 16 or 16 and over), gender, and level of depres-
sion. There was no gender effect on the structure of the
two versions of the ADRS. Factor loadings were however
statistically significantly different across age and depres-
sion groups (all p values < 0.05).
Overall, the results are similar for the initial patient-report
ADRS, especially with regard to the structure of the instru-
ment. However, to be useful in epidemiological studies a
self-report measure should be of a limited size. Therefore
an item reduction procedure was carried out on the initial
44-item self-report. Items were removed on the basis of
clinical considerations (clinical importance of the item
itself), but also on the basis of readability, relevance,
redundancy, item distribution across the different
domains of the depressive experience derived from the
qualitative phase, and statistical considerations (loading <
0.4, inter-item correlation > 0.6).
This procedure yielded a 10-item instrument, ADRSp
(table 2). A factor analysis conducted on this shorter
instrument confirmed a two-factor structure comparable
to the structure of the clinician version reported above
(table 5). We present the Factor analysis of the final
ADRSc and ADRSp for the three groups of the sample.
Scale internal consistency
The internal consistency of the two final versions of the
ADRS was good. The Cronbach alpha coefficient for
ADRSp was 0.74 in the non-depressed group; 0.74 for the
intermediate group and 0.79 for depression group. For the
ADRSc, the Cronbach alpha was 0.78 in the non-
depressed group, 0.75 for the intermediate group and
0.75 for the depression group
Concurrent validity
All instruments were significantly correlated. As shown in
table 6, Pearson correlation coefficients between ADRSc
and the HDRS, BDI and the CGI ranged from 0.62 to 0.8
(all p-values < 0.05). Pearson correlations between the
ADRSp and the HDRS, BDI and the CGI ranged from 0.51
to 0.83 (all p-values < 0.05).
It is noteworthy that the CGI ratings are more strongly cor-
related with the ADRS (self or clinician-rated) than with
Table 4: Maximum Likelihood Factor Analysis of the ADRSc in three groups
Not depressed (n = 137) Depressed according to clinician 
but not to DSM-IV (n = 139)
Depressed according to clinician 
and DSM-IV (n = 126)
Factor 1 Factor 2 Factor 1 Factor 2 Factor 1 Factor 2
Irritability 0.997 -0.031 0.380 -0.020 0.166 0.038
Overwhelming depression 0.340 0.507 0.797 0.168 0.653 0.261
Negative perception of self 0.303 0.209 0.468 0.177 0.343 0.289
Ideas of death 0.314 0.130 0.424 0.095 0.670 0.098
Mental slowness 0.156 0.594 0.208 0.371 0.283 0.292
Sleep 0.222 0.212 0.273 0.068 0.412 0.247
School investment 0.145 0.422 0.149 0.455 0.272 0.629
Leisure 0.137 0.476 0.077 0.919 0.103 0.887
Relationships 0.061 0.488 0.046 0.542 0.277 0.624
Empathetic perception of clinician 0.518 0.487 0.741 0.258 0.658 0.385
ADRSc: Adolescent Depression Rating Scale Clinician versionBMC Psychiatry 2007, 7:2 http://www.biomedcentral.com/1471-244X/7/2
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the HDRS or the BDI-13 (statistically significant with a
bootstrap procedure).
Discriminant validity: contrasted groups
As shown in Table 7, effect sizes of the HDRS, BDI, ADRSc
and ADRSp were compared among the three groups.
These effect sizes are intended to assess the sensitivity of
the ADRS in differentiating groups with and without
depression. The ADRSp shows a larger effect size than the
BDI. This difference was statistically significant at the 5%
level in differentiation of the non-depressed and
depressed groups (including intermediate group). The
ADRSc shows a larger effect size than the HDRS, and this
difference was statistically significant in differentiating the
groups [no depression] and [intermediate depression +
depression] and in differentiating the groups [no depres-
sion + intermediate depression] and [depression].
Receiver operator curve analysis: sensitivity and specificity
The optimal cut-off point was determined by plotting sen-
sitivity versus specificity for each possible cut-off and
examining the point that maximized the summation of
sensitivity and specificity. Here, two binary "gold stand-
ards" can be proposed to compute sensitivity and specifi-
city: depression according the clinical judgment, or
depression according to both clinical judgment and DSM-
IV. Both analyses were performed. For the ADRSp, the cut-
off corresponding to the clinical judgment of depression
was 3 and the cut-off corresponding to the DSM-IV was 4.
For the ADRSc, these cut-offs were 15 and 20, respectively.
Sensitivity and specificity are reported in table 7.
Minimum clinically relevant difference
Finally, minimum clinically relevant variations in score
on a scale are of major interest when interpreting results
of clinical trials or epidemiological studies. This mini-
mum variation can be estimated from the slope coeffi-
cient of the linear regression of ADRS on CGI (Norman et
al. 2001) (Table 7). As a rule-of-thumb, a variation of 5
points on the ADRSc may be considered as the minimum
clinically important difference, while a variation of 1
point is clinically important for the ADRSp.
Discussions and conclusions
The purpose of this study was to develop and validate a
depression scale especially designed for adolescents. Our
Table 6: Pearson's correlations coefficient between ADRS, HDRS, BDI and CGIs
ADRSc ADRSp HDRS BDI CGI
ADRSc - 0.63 0.80 0.61 0.80
ADRSp - 0.56 0.82 0.52
HDRS - 0.52 0.74
BDI - 0.48
CGI -
all p-values < 0.05
ADRSc: Adolescent Depression Rating Scale (clinician version)
HDRS: Hamilton Depression Rating Scale
ADRSp: Adolescent Depression Rating Scale (self-rated version)
BDI: Beck Depression Inventory
CGI: Clinical Global Impression Severity Scale
Table 5: Maximum Likelihood Factor Analysis of the ADRSp in three groups
Not depressed (n = 137) Depressed according to clinician 
but not to DSM-IV (n = 139)
Depressed according to clinician 
and DSM-IV (n = 126)
Factor 1 Factor 2 Factor 1 Factor 2 Factor 1 Factor 2
No energy for work 0.041 0.997 0.125 0.990 -0.014 0.712
Trouble thinking 0.547 0.147 0.246 0.032 0.289 0.344
Overwhelmed by sadness 0.597 0.247 0.613 0.069 0.570 0.190
Nothing really interests me... 0.665 0.107 0.389 0.142 0.579 0.225
What I do is useless 0.413 0.128 0.368 0.193 0.532 -0.001
Ideas of death 0.572 0.175 0.474 0.098 0.614 -0.069
Everything annoys me 0.628 0.046 0.582 0.157 0.474 0.094
Discouraged 0.552 0.207 0.559 0.344 0.507 0.057
Sleep badly 0.225 0.211 0.448 0107 0.599 0.092
Not coping at school/work 0.229 0.510 0.166 0.538 0.076 0.794
ADRSp: Adolescent Depression Rating Scale patient versionBMC Psychiatry 2007, 7:2 http://www.biomedcentral.com/1471-244X/7/2
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study showed that both the clinician and self-report ver-
sions of the ADRS had acceptable psychometric properties
with good convergent, discriminant, and factorial validity,
and good internal consistency.
The final 10-item versions of the clinician-report and self-
report ADRS yielded two factors: "internal state" (items:
irritability, overwhelmed by depression, negative percep-
tions of self, ideas of death, sleep and "external manifesta-
tions" (mental slowness, implication in school, leisure
activities, relationships) (table 2). The factorial structure
of the ADRS reinforces the construct validity of the scale
since it is consistent with the preliminary qualitative
phases of the development the ADRS scales. Depression in
adolescents did indeed appear as a complex emotional state,
involving irritability, a feeling of being overwhelmed by
the depressive experience, negative perceptions of self,
thoughts about death; this is accompanied by non-emo-
tional manifestations: mental slowness, sleep disturbances,
and  manifestations through social interactions at school,
work, in leisure, and in relationships with others.
From the psychometric point of view, the non-emotional
manifestations are divided into two types: one is linked to
the complex emotional state and forms the dimension
"Internal state", the other is linked to manifestations
through social interactions and forms the dimension
"External manifestations". Internal state and external
manifestations are dimensions that are already well
known in depression, and they are described here in a way
that is specific to adolescence. Although deficiencies in
social relationships are not included in the definition of
depression, any exploration of depression should place
strong emphasis on the impact of social skill deficits and
dysfunctional interpersonal behaviours [23].
It can be noted that in the ADRS the item "leisure" in the
clinician version and the item "nothing really interests me
or entertains me" in the self-report version explore mani-
festations of anhedonia, and the item "negative self-per-
ception" explores one facet of a symptom often pointed to
in depression: feelings of worthlessness. Recently, Wilcox
and Anthony [24]) reported that persistent anhedonia
during childhood or adolescence-was 17 times more prev-
alent in a sample of male adults with major depressive dis-
order than in a sample of controls, and this figure
increased to 31–32 times in females. Feelings of worth-
lessness in childhood and adolescence were also associ-
ated with major depressive disorder in adulthood. Pine
[25] and Murphy [26], also pointed to the prognostic sig-
nificance of persistent anhedonia when it appears before
early adulthood.
From a public health standpoint, identifying specific early
clinical features might make it possible to provide antici-
patory guidance or other early interventions that could
prevent or reduce the impact of depressive disorders. In
addition, the small number of items in the ADRS self-
report involves little respondent burden, thereby allowing
it to be combined with other short instruments that screen
for different mental health conditions, enabling its use in
epidemiological studies.
Table 7: Discriminant validity and Minimum clinically relevant difference of ADRSc, ADRSp, HDRS and BDI
ADRSc HDRS ADRSp BDI
mean (sd) mean (sd) mean (sd) mean (sd)
Levels of depression
No depression 8.9 (6.1) 6.0 (4.2) 2.3 (2.5) 8.6 (6.8)
Intermediate group 17.7 (7.6) 11.0 (5.4) 4.1 (2.7) 12.9 (8.3)
Depression 28.2 (8.9) 17.2 (6.2) 6.0 (2.7) 19.4 (8.9)
Effect size
no dep vs (inter+dep) 1.41 1.21 0.94 0.79
(no dep+inter) vs dep 1.51 1.30 1.01 0.94
Sensitivity/specificity Cut-off 15:
0.76/0.80
Cut-off 20:
0.83/0.78
Cut off 3:
0.79/0.60
Cut-off 4:
0.80/0.60
Minimum clinically relevant difference 5.2 3.1 0.9 2.5
ADRSc: Adolescent Depression Rating Scale (clinician version)
HDRS: Hamilton Depression Rating Scale
ADRSp: Adolescent Depression Rating Scale (self-rated version)
BDI: Beck Depression Inventory
No depression: the patients did not meet DSM-IV criteria for MDD and were not judged clinically depressed by the investigator.
Intermediate depression group: the patients did not met the DSM-IV criteria for MDD but were judged clinically depressed.
Depression: the patients met DSM-IV criteria for MDD and were judged clinically depressed.BMC Psychiatry 2007, 7:2 http://www.biomedcentral.com/1471-244X/7/2
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The results of this study need to be considered in light of
the following limitations. First, only five adolescents were
interviewed in the qualitative phase, this may be consid-
ered as a small number, even if a saturation of the verbatim
collected appeared at this stage. Second, the sample under
study was made up of psychiatric and medical outpatients
or inpatients at multiple sites, even if this heterogeneity
may be interesting in terms of generalisability, it may be
criticised on scientific grounds. The strategy used to clas-
sify patients in the sample needs also to be discussed. A
dimensional scale must be able to assess different levels of
depression ranging from none to severe, for instance in
clinical trials before and after treatment. Thus in our sam-
ple, three groups of depressive experience were formed:
the non-depressed group, the intermediate group com-
prising patients who were depressed but not MDD (with-
out consideration of the categories of depression), and the
MDD group. We took the MDD form as the most severe
form of depressive experience [4,24].
Other limitations must be noted. Inter-rater agreement
was not measured in this first validation study. Also, since
there is substantial overlap between anxiety and depres-
sive symptomatology, subsequent studies should evaluate
whether the ADRS differentiates between young people
suffering from anxiety alone and those with depression
[27]. These two points will be studied in a second valida-
tion step.
Finally, no standardized instruments were used to assess
subjects' psychopathology. However, all interviewers were
senior psychiatrists with vast experience in assessing and
treating children with psychiatric disorders. In addition,
to diagnose MDD they used the DSM-IV criteria. Perhaps
a replication study could implement standardized strate-
gies to classify the patients according to depression cate-
gories and to explore co-morbidities.
The ADRSp and ADRSc have been designed and validated
in French (in France, Belgium and Switzerland). Transla-
tions have been made into English (Canadian, American,
British), Spanish, Italian, Arabic and Hebrew. Back-trans-
lations have been performed for all these versions, and
problems remain with the Arabic and Hebrew versions of
the ADRSc and the English version of the ADRSp.
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